Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of OMT-111 in Metastatic Colorectal Cancer Resistant to Standard Therapies
KCT0005343Phase 2Completed
- Sponsor
- MetiMedi Pharmaceuticals
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OMT-111 in colorectal cancer (CRC), sponsored by MetiMedi Pharmaceuticals. Started Jul 2020; status: completed.
02
Drugs
OMT-111
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on KCT0005343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005343.